BIO Stock Summary and Trading Ideas (Bio-Rad Laboratories Class A | NYSE:BIO)

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Bio-Rad Laboratories Class A trades on the NYSE stock market under the symbol BIO.

As of January 14, 2026, BIO stock price declined to $317.45 with 181,120 million shares trading.

BIO has a beta of 0.71, meaning it tends to be less sensitive to market movements. BIO has a correlation of 0.09 to the broad based SPY ETF.

BIO has a market cap of $8.56 billion. This is considered a Mid Cap stock.

Last quarter Bio-Rad Laboratories Class A reported $653 million in Revenue and $2.26 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.18.

In the last 3 years, BIO traded as high as $509.62 and as low as $211.43.

The top ETF exchange traded funds that BIO belongs to (by Net Assets): VTI, IJH, VB, VBR, VXF.

BIO has underperformed the market in the last year with a return of -9.7%, while SPY returned +19.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in BIO shares. However, BIO has outperformed the market in the last 3 month and 2 week periods, returning +4.5% and +4.2%, while SPY returned +4.3% and +0.4%, respectively. This indicates BIO has been having a stronger performance recently.

BIO support price is $316.03 and resistance is $328.31 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BIO shares will trade within this expected range on the day.